Thomson Reuters, a distinguished brokerage company, has placed a 52-week price target of $123.9500 on Edwards Lifesciences Corporation (NYSE:EW) shares after it surveyed top market analysts. Calculating estimated earnings after taking into consideration different elements, it is predicted to come at $2.8700 for the next fiscal and $N/A for underway quarter.
Analysts take into account the price to earnings ratio to estimate the firm’s valuation. This ratio, which is also called as the P/E ratio evaluates the company on relative expense factor. The formula to calculate ratio is stock’s latest price/ per share earnings. The P/E ratio of Edwards Lifesciences Corporation (NYSE:EW) stands at 46.3943.
Analysts also work out Price/Earnings Growth ratio in an attempt to estimate the valuation of a firm. This ratio commonly known as the PEG ratio implies the stock’s valuation compared to earnings growth potential. Investors look to invest in the stocks with a lower PEG ratio. For Edwards Lifesciences Corporatio, the PEG ratio for coming 3-5 years is 2.2200.
The technical analysis highlights that Edwards Lifesciences Corporatio current is trading $4.2542 points away or +3.9383% from its 50-day moving average of $108.0200. Further it is trading $13.4666 or +13.6291% away its 200-day moving average of $98.8076.
The 52-week high of Edwards Lifesciences Corporation (NYSE:EW) was $117.4600 while lowest point recorded in 52-week was $62.5300. It implies if stock price makes a movement of over $-5.1858, it will record a new 52-week high. In the case of +79.5525% drop, it will touch a new 52-week low.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...